• admin@ataxiatelangiectasia.es
Ataxia Telangiectasia
  • Home
  • Bibliography
    • Authors
    • Cells and molecules
    • Clinical
    • Country
    • Diseases
    • Drugs
    • Experimental
    • Journals
    • Methods
    • Year
  • Resources
  • What is A-T?
  • News

Bibliography

  • Quantitative neurologic assessment of ataxia-telangiectasia.
    Hits: 1011
    • ataxia telangiectasia
    • Lederman HM
    • Neurology
    • Lefton-Greif MA
    • Crawford TO
    • Mandir AS
    • Goodman SN
    • Goodman BK
    • Sengul H
    • neurogical assessment
    • 2000
    Neurology. 2000 Apr 11;54(7):1505-9.
    Crawford TO1, Mandir AS, Lefton-Greif MA, Goodman SN, Goodman BK, Sengul H, Lederman HM.

    Author information

    1
    Department of Neurology, Ataxia-Telangiectasia Clinical Center, the John Hopkins Medical Institutions, Baltimore, MD 21287-8811, USA.

    Abstract

    BACKGROUND:

    Ataxia telangiectasia (A-T) is a rare disorder with many distinctive neurologic features. Although there is substantial individual variation in the rate of progression of these features, their relationship to one another or to age has not been characterized.

    METHODS:

    We formulated and tested multiple elements that assess different neurologic functions known to be affected by A-T. The overall index was applied to 52 patients with A-T, 2 to 29 years of age.

    RESULTS:

    Seven elements items proved to be informative, and three elements were added based on face validity. In a linear regression model of individuals under 19 years of age, controlled for correlation within sibships, age accounted for 87% of the variation in the A-T Index.

    CONCLUSION:

    Despite substantial individual variability of the phenotypic elements of A-T, scores on this multidimensional index have a very high correlation with age, indicating that there is a characteristic rate of progression of the disease, although functional domains in the brain are differentially affected. The pattern of scores suggests that a severe and a mild form of A-T may be distinguished by this quantitative measure. With further development this index may become useful as an outcome measure for treatment studies and prognosis.

    PMID:
     
    10751267
    [Indexed for MEDLINE]
  • Oropharyngeal dysphagia and aspiration in patients with ataxia-telangiectasia.
    Hits: 1014
    • Lederman HM
    • Lefton-Greif MA
    • Crawford TO
    • Dysphagia
    • Loughlin GM
    • Winkelstein JA
    • Koerner CB
    • Zahurak M
    • aspiration
    J Pediatr. 2000 Feb;136(2):225-31.
    Lefton-Greif MA1, Crawford TO, Winkelstein JA, Loughlin GM, Koerner CB, Zahurak M, Lederman HM.

    Author information

    1
    Ataxia-Telangiectasia Clinical Center, John's Hopkins Children's Center, Baltimore, MD 21287-3923, USA.

    Abstract

    OBJECTIVES:

    To determine whether patients with ataxia-telangiectasia exhibit oropharyngeal dysphagia with concomitant aspiration and to examine the relationships among swallowing function, age, and nutritional status.

    STUDY DESIGN:

    Seventy patients (mean age, 10.7 years; range, 1.8 to 30 years) had feeding/swallowing and nutritional evaluations. Fifty-one patients, in whom there were concerns about swallowing safety, were examined with a standardized videofluoroscopic swallow study.

    RESULTS:

    Fourteen of the 51 patients (27%) with histories suggestive of dysphagia demonstrated aspiration. Of these, silent aspiration (aspiration without a cough) occurred in 10 (71%) patients. Aspirators were significantly older than non-aspirators (mean age, 16.9 vs 10.8 years; P =.002). Advancing age was the strongest factor associated with aspiration during continuous drinking (P =.01). In patients with ataxia-telangiectasia, weight and weight/height were abnormally low at all ages and most compromised in older patients. Patients who aspirated had significantly lower mean weight (P <.002) and weight/height z scores (P <.001) than did patients who did not aspirate.

    CONCLUSIONS:

    Oropharyngeal dysphagia is common and appears to be progressive in patients with ataxia-telangiectasia. Older patients also have a higher incidence of poorer nutritional status. The relationship between dysphagia and nutritional status deserves further investigation.

    PMID:
     
    10657830
    [Indexed for MEDLINE]
  • Ocular motor abnormalities in ataxia telangiectasia.
    Hits: 1023
    • ataxia telangiectasia
    • Lederman HM
    • Crawford TO
    • eyes
    • ocular motor abnormalities
    • Lewis RF
    • Ann Neurol
    • 1999
    Ann Neurol. 1999 Sep;46(3):287-95.
    Lewis RF1, Lederman HM, Crawford TO.

    Author information

    1
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

    Abstract

    Although abnormal eye movements are a prominent feature of ataxia telangiectasia, the characteristics of the oculomotor dysfunction in the disease have been reported only in small groups of patients. We have examined eye movements clinically in 56 patients with ataxia telangiectasia, and obtained electrooculographic recordings of eye movements in 33 subjects. Deficits were observed in the eye movement systems that stabilize images on the retina, including pursuit, gaze holding, convergence, vestibular and optokinetic slow phases, and cancellation of vestibular slow phases. Abnormalities in the systems that maintain fixation and shift gaze were also prominent, including abnormal reflexive and voluntary saccades (characterized by prolonged latency, hypometric amplitude, and the use of head movements to initiate gaze shifts), impaired fixation, and a reduction in vestibular and optokinetic quick phases. The abnormalities in image stabilization most likely result from dysfunction in the cerebellar flocculus and paraflocculus. The basis of the saccadic and fixation disturbance is less certain but may be the result of abnormal supranuclear control of the superior colliculus resulting from dysfunction in the cerebellar vermis or the basal ganglia.

    PMID:
     
    10482258
    [Indexed for MEDLINE]
  • Ataxia telangiectasia. (review)
    Hits: 990
    • United States of America
    • Crawford TO
    • review
    • Semin Pediatr Neurol
    Semin Pediatr Neuro. 1998 Dec;5(4):287-94.
    Crawford TO1.

    Author information

    1
    Department of Neurology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

    Abstract

    The cloning of ATM in 1995, the gene responsible for ataxia-telangiectasia, opened a dimension of biological research that is as complex and intriguing to cell biologists as this classic disorder has been to clinicians for four decades. The phenotype is both variable and stereotyped, with significant differences between patients in the rate of progression or appearance of the multiple features yet consistent in their characteristic nature. Ataxia telangiectasia usually has been misdiagnosed for the first few years of life, while accurate diagnosis might most impact family planning. Newly produced ATM-deficient transgenic mice express most of the cellular features of the disorder but have yet to mimic the distinctive neurodegeneration.

    PMID:
     
    9874856
    [Indexed for MEDLINE]
  • Consequences of the delayed diagnosis of ataxia-telangiectasia.
    Hits: 1026
    • ataxia telangiectasia
    • United States of America
    • Lederman HM
    • Pediatrics
    • Crawford TO
    • Winkelstein JA
    • 1998
    • Cabana MD
    • Christensen JR
    • delayed diagnosis
    Pediatrics. 1998 Jul;102(1 Pt 1):98-100.

    Consequences of the delayed diagnosis of ataxia-telangiectasia.

    Cabana MD1, Crawford TO, Winkelstein JA, Christensen JR, Lederman HM.

    Author information

    1
    Ataxia-Telangiectasia Clinical Center, Johns Hopkins Children's Center, Baltimore, MD 21287-3923, USA.

    Abstract

    OBJECTIVES:

    Ataxia-telangiectasia (AT) is a rare, autosomal recessive neurodegenerative disorder in which the diagnosis is obvious when ataxia and telangiectasia are both present. However, the diagnosis can be made upon the onset of ataxia and before the appearance of telangiectasia if confirmed by laboratory tests. Early diagnosis is important for genetic counseling, appropriate care, and avoidance of unnecessary tests. The purpose of this study is to identify factors responsible for delays in the diagnosis of AT.

    DESIGN:

    The records of all patients seen at the Ataxia-Telangiectasia Clinical Center from July 1, 1995 to April 1, 1997 were reviewed to determine age of onset of gait abnormality, recognition of telangiectasia, and diagnosis.

    RESULTS:

    In 48 patients with AT, who were the index cases in their respective families, the median age of diagnosis (78 months) occurred after the onset of gait abnormalities (15 months) and closely corresponded to the development of telangiectasia (72 months). In the majority of cases (34/48), telangiectasia appeared before the diagnosis was established. The most common misdiagnosis was cerebral palsy (29/48 cases). Twenty-one children (4 with AT) were born after the start of symptoms in the index case, but before the establishment of a diagnosis.

    CONCLUSIONS:

    The term AT, although a concise and memorable label for the disorder, is also a barrier to early diagnosis. We recommend the use of routine serum alpha-fetoprotein testing for all children with persistent ataxia.

    PMID:
     
    9651420
    [Indexed for MEDLINE]
  • Signal transduction through the B cell antigen receptor is normal in ataxia-telangiectasia B lymphocytes.
    Hits: 1005
    • B cells
    • J Biol Chem
    • Lederman HM
    • Speck P
    • Ikeda M
    • Ikeda A
    • Longnecker R
    J Biol Chem. 2002 Feb 8;277(6):4123-7. Epub 2001 Dec 3.
    Speck P1, Ikeda M, Ikeda A, Lederman HM, Longnecker R.

    Author information

    1
    Department of Microbiology-Immunology, Northwestern University Medical School, Chicago, Illinois 60611, USA.

    Abstract

    The rare human genetic disorder ataxia-telangiectasia (A-T) has multiple consequences including a variable degree of immunodeficiency. Khanna and co-workers (Khanna, K. K., Yan, J., Watters, D., Hobson, K., Beamish, H., Spring, K., Shiloh, Y., Gatti, R. A., and Lavin, M. F. (1997) J. Biol. Chem. 272, 9489-9495) evaluated signaling in Epstein-Barr virus (EBV) immortalized A-T lymphoblastoid cell lines (LCLs), derived from the B cells of A-T patients. They showed that A-T lymphoblastoid cells lack signaling through the B cell antigen receptor and concluded that the fault in A-T encompasses intracellular signaling in B cells. However, it is established that EBV latent membrane protein 2A (LMP2A) blocks signaling in EBV-bearing cells by interaction with cellular tyrosine kinases. To test whether the reported fault in A-T B cells was not inherent in A-T but the result of influence of wild-type EBV, we derived A-T LCLs with wild-type or LMP2A-deleted EBV and studied signaling in these cells in response to cross-linking the B cell antigen receptor. We report that intracellular calcium mobilization and tyrosine phosphorylation in LMP2A-depleted LCLs derived from A-T patients is indistinguishable from that in LMP2A-depleted LCLs derived from normal controls. Further, signaling is blocked similarly in A-T and normal lymphoblastoid cells bearing wild-type EBV. In conclusion there is no evidence of any defect in B cell receptor signal transduction in A-T B cells.

    PMID:
     
    11733529
     
    DOI:
     
    10.1074/jbc.M110109200
    [Indexed for MEDLINE] 
    Free full text
  • Oligo-/monoclonal gammopathy and hypergammaglobulinemia in ataxia-telangiectasia. A study of 90 patients.
    Hits: 998
    • ataxia telangiectasia
    • United States of America
    • Lederman HM
    • Winkelstein JA
    • 1999
    • monoclonal gammopathy
    • hypergammaglobulinemia
    • Medicine (Baltimore)
    • Sadighi Akha AA
    • Humphrey RL
    • Loeb DM
    Medicine (Baltimore). 1999 Nov;78(6):370-81.
    Sadighi Akha AA1, Humphrey RL, Winkelstein JA, Loeb DM, Lederman HM.

    Author information

    1
    Division of Immunology, Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.

    Abstract

    We investigated the presence of hypergammaglobulinemia and oligo-/monoclonal gammopathy in 90 patients (from 80 families) with ataxia-telangiectasia ranging in age from 2 to 29 years. Of the 90 patients, 38.8% displayed hypergammaglobulinemia. An isolated increase in IgM was the most common finding (23.3%) followed by a simultaneous increase in IgM and IgG (8.8%), an isolated increase in IgA (3.3%), an elevated level of IgG (2.2%) and a concomitant increase in IgM and IgA (1.1%), respectively. Seven of the patients (8.1%) had oligo-/monoclonal gammopathy. The gammopathies included all major immunoglobulin isotypes. Chemotherapeutic intervention in 2 cases precipitated the emergence of new clones within a matter of weeks. Further investigation of oligo-/monoclonal gammopathies in these patients may lead to a clearer understanding of the clinical course and provide further insight into the underlying mechanisms of B-cell abnormalities in ataxia-telangiectasia.

    PMID:
     
    10575419
    [Indexed for MEDLINE] 
    Free full text
  • Ataxia-telangiectasia: without ataxia or telangiectasia?
    Hits: 912
    • ataxia
    • United States of America
    • telangiectasias
    • Gatti RA
    • Neurology
    • 2009
    • Saunders-Pullman RJ
    Neurology. 2009 Aug 11;73(6):414-5. doi: 10.1212/WNL.0b013e3181b39140. Epub 2009 Jul 15.
    Saunders-Pullman RJ, Gatti R.

    Comment on

    • Clinical spectrum of ataxia-telangiectasia in adulthood. [Neurology. 2009]
    PMID:
     
    19605768
     
    DOI:
     
    10.1212/WNL.0b013e3181b39140
    [Indexed for MEDLINE]
  • Simultaneous presentation of 2 rare hereditary immunodeficiencies: IL-12 receptor beta1 deficiency and ataxia-telangiectasia.
    Hits: 1142
    • immunodeficiency
    • case
    • Gatti RA
    • J Allergy Clin Immunol
    • Ehlayel M
    • de Beaucoudrey L
    • Fike F
    • Nahas SA
    • Feinberg J
    • Casanova JL

    J Allergy Clin Immunol. 2008 Dec;122(6):1217-9. doi: 10.1016/j.jaci.2008.07.005. Epub 2008 Aug 20.

    Ehlayel M, de Beaucoudrey L, Fike F, Nahas SA, Feinberg J, Casanova JL, Gatti RA.
    PMID:
     
    18718650
     
    DOI:
     
    10.1016/j.jaci.2008.07.005
    [Indexed for MEDLINE]
  • Intact T cell responses in ataxia telangiectasia.
    Hits: 3111
    • ataxia telangiectasia
    • Gatti RA
    • Clin Immunol
    • 2006
    • T Cells
    • Pashankar F
    • Singhal V
    • Akabogu I
    • Goldman FD
    Clin Immunol. 2006 Aug;120(2):156-62. Epub 2006 Jun 8.
    Pashankar F1, Singhal V, Akabogu I, Gatti RA, Goldman FD.

    Author information

    1
    Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520, USA.

    Abstract

    Ataxia telangiectasia (A-T) is an autosomal recessive multisystem disorder associated with a variable immune deficiency. The mechanism for this remains unclear. Qualitative and quantitative defects of cellular immunity have been previously reported. However, despite laboratory evidence of significant immune abnormalities, opportunistic infections are uncommon. To address this discrepancy, we analyzed cytokine production by quantitative real-time PCR and T cell function at the single cell level by flow cytometry in four A-T patients. CD4 and CD8 T cell subsets from these patients displayed intact signaling in response to anti-CD3 stimulation, similar to controls. Stimulated T cells from A-T patients also produced normal to increased levels of Th1 (IL-2, IFN-gamma) and Th2 (IL-10, IL-4) cytokines, relative to control values. Our results suggest that T cells from A-T patients may be more functionally intact than previously observed. This helps to explain the paucity of opportunistic infections encountered, unlike that encountered in other primary immunodeficiencies.

    PMID:
     
    16762595
     
    DOI:
     
    10.1016/j.clim.2006.04.568
    [Indexed for MEDLINE]

Page 19 of 42

  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23

Language

Select your language

  • Hindi (India)
  • Hebrew
  • Arabic (اللغة العربية)
  • Turkish (Turkey)
  • 日本語 (Japan)
  • Russian (Russia)
  • Français (France)
  • Deutsch (Deutschland)
  • Español (España)
  • Nederlands (nl-NL)
  • Português Brasileiro (pt-BR)
  • Polski (PL)
  • Italiano (Italia)
  • English (United Kingdom)

Tweets by A_Tinfo

  • Sitemap
Ataxia Telangiectasia
  • Home
  • Bibliography
    • Authors
    • Cells and molecules
    • Clinical
    • Country
    • Diseases
    • Drugs
    • Experimental
    • Journals
    • Methods
    • Year
  • Resources
  • What is A-T?
  • News
  • admin@ataxiatelangiectasia.es